Loading...

OTC Markets

Totals

Securities

12,256

Dollar Vol

$50.5M

Share Vol

12.8M

Trades

1,245

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
ATTBF
Financials

ATTBF
Abattis Bioceuticals Corp.

Ordinary Shares

Financials

Fiscal year ends 9/30

| Values in 000s USD

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

2021

12/30/2021

2020

12/30/2020

2019

12/30/2019

2018

12/30/2018

12/30/2021

2021-12-31 00:00:00

12/30/2020

2021-12-31 00:00:00

12/30/2019

2021-12-31 00:00:00

12/30/2018

2021-12-31 00:00:00

Revenues

Total Revenue

178

588

178

233

178

Cost of Revenue

158

Gross Profit

148

430

148

218

148

Operating Expenses

Research and Development

102

Sales, General and Admin

221

553

221

381

221

129

221

Non-Recurring Items

1,253

Other

518

628

518

445

518

186

518

Total Expenses

2,058

1,284

2,058

888

2,058

362

2,058

Operating Income

(1,909)

(854)

(1,909)

(669)

(1,909)

(302)

(1,909)

Income from Continuing Operations

Additional Income / Expense Items

(31)

(43)

Earnings Before Interest and Taxes

(1,909)

(854)

(1,909)

(669)

(1,909)

(302)

(1,909)

Interest Expense

(12)

(21)

(26)

Earnings Before Tax

(1,895)

(930)

(1,895)

(644)

(1,895)

(372)

(1,895)

Income Tax

Minority Interest

Equity Earnings

Net Income Cont. Operations

(1,895)

(930)

(1,895)

(644)

(1,895)

(372)

(1,895)

Non-Recurring Events

Discontinued Operations

Extraordinary Operations

Effect of Accounting Changes

Net Income

(1,895)

(930)

(1,895)

(644)

(1,895)

(372)

(1,895)

Key Financial Ratios

Earnings Per Share

-0.06

-0.03

-0.06

-0.04

-0.06

-0.02

-0.06

Price/Earnings

Gross Margin

0.8357

0.7307

0.8357

0.939

0.8357

0.8556

0.8357

Operating Margin

-10.7251

-1.4511

-10.7251

-2.8703

-10.7251

-4.2809

-10.7251

Financial data presented is provided by Edgar Online and may differ from information contained in the issuer's annual and periodic reports, which are available under the "Disclosure" tab.

Neither the issuer nor OTC Markets Group is liable for any errors, omissions or other defects in the data presented below, or for any decisions taken in reliance of the data.

For information not originally reported in U.S. Dollars, conversion is based on applicable exchange rate on the last day of the period reported.

© 2025 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Market Groups Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.